Pala, Laura

Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis

Conforti, F., Pala, L., Bagnardi, V., De Pas, T., Martinetti, M., Viale, G., Gelber, R. D., & Goldhirsch, A. (2018) · The Lancet Oncology

Cancer Immunotherapy and BiomarkersSex and Gender in Healthcare

Cited by 973

Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice

Cortellini, A., Tucci, M., Adamo, V., Stucci, L. S., Russo, A., Tanda, E. T., Spagnolo, F., Rastelli, F., Bisonni, R., Santini, D., et al. (2020) · Journal for ImmunoTherapy of Cancer

Cancer Immunotherapy and BiomarkersFerroptosis and cancer prognosis

Cited by 275

Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis

Conforti, F., Pala, L., Bagnardi, V., Viale, G., De Pas, T., Pagan, E., Pennacchioli, E., Cocorocchio, E., Ferrucci, P. F., De Marinis, F., et al. (2019) · JNCI: Journal of the National Cancer Institute

Cancer Immunotherapy and BiomarkersLung Cancer Research Studies

Cited by 262

Glucagon‐like peptide 1 ( GLP1 ) receptor agonists and risk for ischemic optic neuropathy: A meta‐analysis of randomised controlled trials

Silverii, G. A., Pala, L., Cresci, B., & Mannucci, E. (2025) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementDrug-Induced Ocular Toxicity

Cited by 49